Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Insights are our digital media bag

    White Papers and Resources | August 18, 2017 | Four Agency Worldwide

    Life at Four Health Media has been pretty busy this last 12 months. We have a new name (we were previously Four MSA), our team has grown, we have new...

    How to create a multi-channel marketing strategy and plan

    White Papers and Resources | August 17, 2017 | An agency called Owen

    You know what it is and why you need one, now find out how to create a successful pharma multi-channel marketing strategy and plan

    Biosimilars: Getting the flock to market

    White Papers and Resources | August 17, 2017 | Life Healthcare Communications

    The biosimilars field is about to become very crowded. Here are some Life tips on how to stand out from the herd

    Creative effectiveness: how to achieve tangible results

    White Papers and Resources | August 17, 2017 | Blue Latitude Health

    Chris Field, Director and Head of Creative Services at Blue Latitude Health, reveals what it takes to create winning creative campaigns that achieve results in the Pharma market.

    Lucid’s Creative Services team grows

    Press Releases | August 16, 2017 | Lucid Group Communications Limited

    A vital part to delivering exceptional medical education programmes is the design of clever branding and engaging visual elements. Lucid Group pride themselves in the quality of their digital and...

    Being social – harnessing the power of social media

    White Papers and Resources | August 14, 2017 | Porterhouse Medical Group

    With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...

    Leading Edge bolsters its delivery team

    Press Releases | August 11, 2017 | Lucid Group Communications Limited

    After earlier announcements that Lucid Partners was growing its medical writing team, Leading Edge (a Lucid Group company) proudly announces that it is strengthening its delivery team.Francesca Worthington joined Leading Edge...

    How to build an online medical information service that resonates with your customers

    White Papers and Resources | August 9, 2017 | Blue Latitude Health

    Sourcing medical information is a top challenge for healthcare professionals in 2017. Here, Blue Latitude Health Associate Consultant Jiayi Chen gives you the inside scoop on how to build a...

    You know more about your audience than you think

    White Papers and Resources | August 9, 2017 | Four Agency Worldwide

    Our Digital Lead, Richard Springham, discusses the untapped resources of your digital tools and how they hold the key to targeting your audiences.

    How will the NHS’s new medicines savings drive affect pharma?

    White Papers and Resources | August 9, 2017 | Wilmington Healthcare

    Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets